Skip to main content

Table 4 Base case results

From: Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: an Australian perspective

 

Treatment costs

Surveillance costs

Total costs

Pr (sarcoma death)

QALYs

ICER

No surveillance

$42,483

$0

$42,483

0.426

7.50

 

CT

$44,357

$4032

$48,389

0.402

7.69

$30,743

MRI

$39,266

$8068

$47,334

0.426

7.48

Dominated

CT + MRI

$44,202

$10,654

$54,857

0.393

7.76

$96,556

PET

$43,988

$25,567

$69,555

0.394

7.75

Dominated